Wikidata

(Q46129530)

English

A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome

scientific article published on 18 June 2008

In more languages
default for all languages
No label defined

No description defined

Statements

title
A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18565239
retrieved
19 December 2017
reference URL
http://europepmc.org/abstract/MED/18565239

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46129530&oldid=2093904509"